FDA Inspection 1301806 — Boris Mladenov, MD
The FDA completed an inspection of Boris Mladenov, MD on January 9, 2026 in Sofiya. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 9, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Sofiya (Bulgaria)
Additional Details
Clinical Investigator (CI)